Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-30 @ 3:39 AM
Study NCT ID:
NCT03490292
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2018-02-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Sponsor:
University of Wisconsin, Madison
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UW17106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None